Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

New endothelin antagonists from Zeneca

Jan. 22, 1997

New agents for treating encephalopathies from Takeda

Jan. 22, 1997

New antimigraine drug candidates from Lilly

Jan. 22, 1997

Yamanouchi reports 5-HT3 agonists for GI indications

Jan. 22, 1997

Histamine H3 receptor antagonists in development at Gliatech

Jan. 22, 1997

GI motility stimulants reported by Janssen

Jan. 22, 1997

New 5-HT1A receptor ligands reported by Bayer

Jan. 21, 1997

New cardiovascular agents from Sigma-Tau

Jan. 21, 1997

Suntory reports new agents for circulatory disorders

Jan. 21, 1997

Sumitomo reports novel hCNTF variant

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...